Close Menu
    What's Hot

    Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

    September 1, 2026

    Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

    September 1, 2026

    New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

    August 27, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Pacific Life Re Completes Third Asset-Intensive Flow Reinsurance Transaction in Japan

      August 19, 2026

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

      September 1, 2026

      Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

      September 1, 2026

      Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

      August 26, 2026

      New Stress Test Shows UK Bulk Purchase Annuity Insurers on Solid Ground

      August 26, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Wells Fargo Bank, N.A. v. Ameritas Life Insurance Corp

      August 26, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

      September 1, 2026

      Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

      September 1, 2026

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

      August 26, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    Longevity and Mortality Risk Transfer July 22, 2026By ArentFox Schiff
    Share
    Twitter LinkedIn Email

    Viva Capital Trust v. Garrett 

    On July 1, the South Dakota Supreme Court issued a unanimous decision affirming summary judgment in favor of a life settlement investor, holding that the investor was entitled to retain the full $10 million death benefit under a life insurance policy that the insured’s estate had sought to void as an alleged stranger-originated life insurance (STOLI) arrangement. 

    The decision is a significant positive development for investors in the life settlement industry, as it reinforces the enforceability of premium-financed policies where statutory insurable interest requirements are met at inception and confirms that downstream purchasers may rely on the principle of free alienability of validly issued policies.  

    In 2006, Frank Garrett, Jr., a 78-year-old California retiree with a net worth of approximately $20-25 million (consisting primarily of real estate holdings), obtained a $10 million life insurance policy from MassMutual through a premium financing arrangement. The policy was held by an irrevocable trust established by Garrett and governed by South Dakota law, with a South Dakota commercial bank serving as trustee and Garrett’s wife, Jean, named as the trust’s beneficiary. The premiums were financed through a nonrecourse loan from a premium finance lender, United National Funding, LLC, collateralized by the policy itself, with a scheduled maturity of seven years. Two independent insurance agents testified during discovery that Garrett’s purpose in acquiring the policy was to facilitate estate planning — specifically, to provide liquidity for estate taxes and financial security for his wife — and that the policy was not acquired with any prearranged intent to sell. 

    After the initial two-year nonrecourse financing period expired, Garrett explored several options, including refinancing and selling the policy on the secondary market, before ultimately surrendering it to the lender’s successor, New Stream, in 2009, as satisfaction of the outstanding loan obligations. The policy subsequently changed hands through additional secondary market transactions until Viva Capital Trust acquired it in December 2014. Viva paid over $4.4 million in additional premiums to keep the policy in force. After Garrett died in January 2019, MassMutual paid the $10 million death benefit to Viva’s securities intermediary.  

    In 2022, Garrett’s son, as special administrator of the estate, filed counterclaims alleging that the policy was procured through a STOLI scheme that violated South Dakota’s insurable interest statute, SDCL 58-10-3, and sought disgorgement of the death benefit under SDCL 58-10-5. The estate also challenged the validity of the underlying trust, alleging fraud, undue influence, and lack of capacity. The circuit court granted summary judgment to Viva on all claims, and the South Dakota Supreme Court affirmed in a unanimous opinion authored by Justice Patricia Devaney.  

    The court’s analysis proceeded on two principal grounds. First, the court held that the estate’s claims challenging the validity of the irrevocable trust were time-barred under SDCL 55-4-57(a)(1), South Dakota’s statute of repose, which precludes judicial proceedings contesting whether an irrevocable trust was validly created if commenced later than one year after the settlor’s death. Because Garrett died in January 2019 and the estate did not file its counterclaims until June 2022, the challenge was untimely by more than two years. The court construed this provision expansively, holding that it applies to any claims that would negate the valid creation of trusts, encompassing allegations of fraud in execution, undue influence, lack of capacity, and even assertions that the trust lacked a lawful purpose. The court rejected the estate’s attempt to characterize its claims as falling outside the statute’s reach merely because the ultimate remedy sought was recovery of insurance proceeds rather than trust property.  

    Second, turning to the insurable interest question, the court applied the plain and unambiguous text of SDCL 58-10-3, which permits any individual to procure insurance on his own life for the benefit of any person, and prohibits procurement on the life of another only where the benefits are not payable to a person with an insurable interest. The court held that regardless of how the term “procure” is defined — whether narrowly as the estate urged or more broadly as Viva argued — the statute is satisfied so long as the policy benefits were payable to a person having an insurable interest in the insured’s life at the time the contract was made. Because the death benefits were payable to the trust as policy beneficiary, and ultimately to the insured’s wife, Jean, as the trust’s beneficiary, and because both the trustee and Jean held statutory insurable interests under SDCL 58-10-4(1) and (6), the insurable interest requirement was met.  

    Although the court acknowledged that many features of the transaction “align with a typical STOLI scheme” — including nonrecourse premium financing, the formation of an irrevocable trust with a lender-selected trustee, a collateral assignment, and the eventual surrender of the policy to the lender — the court identified several undisputed facts distinguishing this case from situations where courts have voided policies as unlawful wagers. These included Garrett’s substantial personal wealth and legitimate estate planning motivations, the absence of any upfront payment or financial inducement to the insured, the seven-year loan term (as opposed to a maturity timed merely to the two-year contestability period), the insurer’s documented awareness of the premium financing arrangement, and the fact that for over three years the policy proceeds would have been payable to the trust for Jean’s benefit.  

    The court further cited SDCL 58-10-6.1, which expressly provides that no transfer of a validly issued policy shall be invalid by reason of a lack of insurable interest of the transferee, reinforcing the well-established principle from Grigsby v. Russell, 222 U.S. 149 (1911), that a life insurance policy has the ordinary characteristics of freely alienable property.  

    Notably, the court observed that South Dakota has not enacted anti-STOLI legislation, unlike approximately 30 other states that have done so, and stated that where courts “cannot devise a bright-line rule,” the matter “is best addressed by the Legislature.” This expression of judicial deference signals that South Dakota courts are unlikely to expand common-law doctrines to invalidate policies that comply with existing statutory requirements, absent legislative action.  

    The Garrett decision is a favorable ruling for the life settlements industry. It confirms that premium-financed policies are not inherently suspect and will not be voided in South Dakota, where the named beneficiary holds a valid insurable interest at inception. It also establishes that downstream life settlement purchasers may rely on the statutory principle of free transferability without concern that a policy’s secondary market history will be used to retroactively invalidate it. Moreover, for policies held in South Dakota trusts, the one-year statute of repose creates a short, definitive deadline beyond which estates cannot mount challenges to trust validity, providing meaningful finality protections for investors.  

    Finally, the court’s textualist approach to the insurable interest statute is consistent with the methodology employed by the Georgia Supreme Court earlier this year in the Leone case (Wilmington Tr. Co. v. Sun Life Assur. Co. of Canada, 323 Ga. 657 (2026)), suggesting an emerging judicial consensus that plain statutory compliance governs the validity inquiry.

    By ArentFox Schiff’s Insurance & Reinsurance Practice Group.

    You can find the original version of this article, which is reproduced here in full, at https://www.afslaw.com/perspectives/alerts/south-dakota-supreme-court-upholds-life-settlement-investors-right-retain-10.    

    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Longevity and Mortality Investor or its publisher, the European Life Settlement Association

    2026 - July Life Settlement Litigation Life Settlements Volume 2 Issue 8 – August 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Litigation

    Litigation Update: Wells Fargo Bank, N.A. v. Ameritas Life Insurance Corp

    August 26, 2026By Greg Winterton

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026By Chris Wells

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026By Greg Winterton
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.